Testing for Cytomegalovirus Among Individuals Who Were Immunocompromised, 2018-2022

JAMA Netw Open. 2023 Nov 1;6(11):e2345126. doi: 10.1001/jamanetworkopen.2023.45126.
No abstract available

Plain language summary

This cohort study investigates rates of cytomegalovirus testing before and during the COVID-19 pandemic among individuals who were immunocompromised.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytomegalovirus Infections* / diagnosis
  • Cytomegalovirus*
  • Humans
  • Immunocompromised Host